Main Content start here
Main Layout
Report Description

Report Description

Forecast Period

2026-2030

Market Size (2024)

USD 6.23 Billion

Market Size (2030)

USD 7.87 Billion

CAGR (2025-2030)

3.97%

Fastest Growing Segment

Direct Sales

Largest Market

North America

Market Overview

Global Liquid Oxygen Devices Market was valued at USD 6.23 billion in 2024 and is expected to reach USD 7.87 billion by 2030 with a CAGR of 3.97% during the forecast period. The Global Liquid Oxygen Devices Market encompasses a diverse range of medical equipment designed to store and deliver liquid oxygen to patients. These devices play a crucial role in the treatment of respiratory conditions and are widely used in both hospital settings and for home healthcare.

Key Market Drivers

Increasing Prevalence of Respiratory Diseases

Respiratory diseases have become a global health concern, affecting millions of people across the world. As the prevalence of respiratory conditions continues to rise, the demand for medical solutions, such as liquid oxygen devices, has surged.

Respiratory diseases encompass a broad spectrum of conditions, including chronic obstructive pulmonary disease (COPD), asthma, bronchitis, and pulmonary fibrosis. They are characterized by symptoms like shortness of breath, wheezing, and coughing, which can significantly impact a patient's quality of life.

Environmental factors, such as air pollution, play a major role in the development of respiratory conditions. Prolonged exposure to pollutants, both indoors and outdoors, increases the risk of developing lung diseases. As industrialization and urbanization continue to expand, air quality concerns persist. Smoking is a leading cause of respiratory diseases, particularly COPD and lung cancer. Despite ongoing anti-smoking campaigns and regulations, tobacco use remains prevalent in many regions, contributing to the burden of respiratory conditions. The global population is aging, with a larger proportion of elderly individuals who are more susceptible to respiratory diseases. Aging is associated with a natural decline in lung function, making older adults more vulnerable to these conditions. Sedentary lifestyles, unhealthy diets, and obesity are additional risk factors for developing respiratory diseases. These lifestyle choices are increasingly common in both developed and developing countries.

For example, in 2021, the National Centre for Environmental Health reported that approximately 25 million individuals in the US had asthma, representing 7.7% of the population, which marked an increase from 20.3 million in the previous decade. Additionally, in June 2023, the American Lung Association revealed that about 15.6 million adults (6.4 percent) had been diagnosed with COPD in 2021, highlighting the growing need for liquid oxygen devices.

With a larger pool of individuals experiencing respiratory symptoms, more patients are seeking medical evaluation and diagnosis. This, in turn, leads to a greater number of prescriptions for oxygen therapy, boosting the demand for liquid oxygen devices. Many patients with advanced respiratory conditions, like COPD, require long-term oxygen therapy to maintain their oxygen levels and quality of life. Liquid oxygen devices are a preferred choice for these patients, as they offer efficient and continuous oxygen supply. The rising awareness of home healthcare options has led to an increasing preference for receiving oxygen therapy in the comfort of one's own home. Liquid oxygen devices are well-suited for home use due to their portability, making them an essential component of home healthcare solutions. As the prevalence of respiratory diseases grows, medical device manufacturers are driven to invest in research and development to create more effective and user-friendly liquid oxygen devices. These advancements further promote their adoption and use. Government healthcare policies and insurance coverage have expanded to accommodate the needs of patients with respiratory diseases. These programs often cover a significant portion of the cost of liquid oxygen devices, making them more accessible to patients.

Home Healthcare Trend

The global healthcare landscape is undergoing a significant transformation, with an increasing emphasis on home-based care. This shift is driven by a combination of factors, including patient preferences, the need for more cost-effective healthcare solutions, and the advancement of medical technology. Among the beneficiaries of this trend is the global market for liquid oxygen devices, which play a pivotal role in enabling patients to receive oxygen therapy in the comfort of their homes.

Patients prefer to receive care in their homes as it provides a more patient-centered approach to treatment. It allows them to maintain a sense of independence, familiarity, and control over their health management. Home-based care is often more cost-effective than traditional hospital care. It can lead to a reduction in hospital readmissions and healthcare expenses, making it an attractive option for healthcare providers, insurance companies, and patients. The rapid growth of telehealth services, including remote monitoring and virtual consultations, has made it easier for healthcare professionals to assess and treat patients from a distance. This, in turn, supports the home healthcare trend. The aging global population has created a greater need for healthcare services. Many older adults prefer to age in place and receive care at home, further driving the demand for home healthcare solutions.

Liquid oxygen devices are often lightweight and portable, allowing patients to move freely within their homes and even travel while receiving oxygen therapy. This mobility is crucial for patients' well-being and quality of life. Patients with chronic respiratory conditions, such as chronic obstructive pulmonary disease (COPD), often require a constant oxygen supply. Liquid oxygen devices provide a reliable source of oxygen, ensuring patients receive the therapy they need without interruption. Manufacturers have invested in user-friendly designs, making liquid oxygen devices easy to use and maintain. This is vital for patients and caregivers, who may not have specialized medical training. Home healthcare solutions, including liquid oxygen devices, alleviate the burden on healthcare facilities, freeing up resources for patients with more acute needs. This is especially crucial in times of healthcare system strain, such as during pandemics.

Awareness of Oxygen Therapy

The global healthcare landscape is witnessing a notable shift in the awareness and understanding of various medical treatments, including oxygen therapy. As more patients, caregivers, and healthcare professionals recognize the benefits of oxygen therapy, the global market for liquid oxygen devices is experiencing a surge in demand.

Oxygen therapy is a medical treatment that involves the administration of supplemental oxygen to individuals with low blood oxygen levels. This therapy is vital for patients with a wide range of conditions, including chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and respiratory distress syndrome. Its primary goal is to enhance the body's oxygen supply, alleviating symptoms and improving the patient's quality of life. The therapy can be delivered in various ways, with liquid oxygen devices being one of the preferred methods due to their efficiency and portability.

Several government bodies are launching healthcare initiatives to support various sectors, including the development and adoption of liquid oxygen devices. For example, in 2022, the UK government allocated £260 million (approximately US $270.65 million) to enhance healthcare research and manufacturing. This funding, provided by the Department of Health and Social Care and the Department for Business, Energy & Industrial Strategy (BEIS), aims to support NHS-led research in diagnostics and treatment through innovative privacy-preserving platforms and clinical research services. 

Patients are now more informed about their medical conditions and treatment options. This increased access to information, often facilitated by the internet, empowers patients to advocate for their health and request the best available treatments, including oxygen therapy. Healthcare professionals are better educated and more attuned to the benefits of oxygen therapy. They are increasingly likely to prescribe oxygen therapy when necessary, ensuring that more patients receive proper treatment.  Advocacy groups and healthcare organizations dedicated to respiratory health play a crucial role in raising awareness about oxygen therapy. They provide resources, information, and support to patients and their families, helping them understand the importance of therapy. Media outlets and healthcare awareness campaigns have taken up the cause of promoting oxygen therapy as an essential medical intervention. Public service announcements and informational materials have contributed to the broader understanding of its value.

As patients become more knowledgeable about the symptoms and signs of respiratory conditions, they are more likely to seek medical evaluation and diagnosis. This, in turn, leads to a higher rate of prescriptions for oxygen therapy, creating a surge in demand for liquid oxygen devices. Patients are increasingly opting for home-based healthcare solutions. Liquid oxygen devices are pivotal for enabling oxygen therapy in the home environment, providing patients with a sense of independence and comfort while receiving essential treatment. As awareness increases, manufacturers are driven to invest in the development of more advanced, user-friendly, and portable liquid oxygen devices. These innovations meet the rising demand for efficient and convenient therapy solutions.

Expanding Healthcare Infrastructure

Healthcare infrastructure is the backbone of a nation's ability to provide quality medical care and support to its population. As countries worldwide invest in enhancing their healthcare facilities and services, one sector that is experiencing significant growth is the global market for liquid oxygen devices.

As the global population continues to expand, the demand for healthcare services increases. Healthcare infrastructure must grow to accommodate the growing number of patients and their diverse medical needs. Advances in medical technology are reshaping the healthcare industry. New and innovative medical devices, including liquid oxygen devices, are being developed to meet the evolving healthcare demands. Governments worldwide are investing in healthcare infrastructure to improve the quality and accessibility of medical services. Initiatives may include the construction of new hospitals, upgrading existing facilities, and training healthcare personnel. Expanding healthcare infrastructure is often focused on extending services to rural and underserved areas. This ensures that healthcare is accessible to a broader population, even in remote regions.

Additionally, £60 million (around US $63.6 million) was designated to expand life sciences manufacturing in the UK, highlighting the government’s commitment to driving advancements in healthcare, including the development of liquid oxygen devices.

Expanding healthcare infrastructure improves access to healthcare services, which includes oxygen therapy. As more people gain access to medical facilities, there is a concurrent rise in the demand for liquid oxygen devices to support respiratory treatments. With improved healthcare infrastructure, there is an increase in early diagnosis and effective treatment of respiratory conditions. Patients are more likely to receive oxygen therapy as a part of their treatment plan, further boosting the demand for liquid oxygen devices. Robust healthcare infrastructure often extends to home healthcare services, which are increasingly popular. Liquid oxygen devices are a vital component of home healthcare, as they allow patients to receive oxygen therapy while maintaining their independence and quality of life. The integration of advanced medical technologies within healthcare infrastructure supports the use of state-of-the-art liquid oxygen devices. These technologies enhance patient care and encourage the adoption of these devices.

For instance, in August 2021, the Delhi Government notified and approved the Medical Oxygen Production Promotion Policy of Delhi, 2021 to ensure there is no shortage of medical oxygen in the wake of Covid 19.  This policy aimed to ensure time-bound fulfillment of the targets such as setting up liquid oxygen (LOX) manufacturing facilities, non-captive & captive oxygen generation plants, and others, thereby boosting the market.

Liquid Oxygen Devices Market

Download Free Sample Report

Key Market Challenges

Regulatory Compliance and Quality Assurance

Ensuring that liquid oxygen devices meet stringent regulatory standards and quality assurance requirements is a significant challenge. Manufacturers must navigate complex and evolving regulations to maintain the safety and efficacy of their products. Failure to comply with these regulations can result in product recalls and legal consequences.

Cost and Accessibility

The cost of liquid oxygen devices and oxygen therapy itself can be a barrier for many patients, especially in regions with limited healthcare coverage. While advancements in technology have improved device efficiency, the overall cost of therapy remains a challenge, and accessing these devices can be financially burdensome for some individuals.

Insurance and Reimbursement Policies

Insurance and reimbursement policies vary by country, region, and even insurance provider. Navigating the complex landscape of reimbursement can be challenging for both patients and healthcare providers. Some insurance plans may not fully cover the cost of liquid oxygen devices, leading to financial strain for patients.

Key Market Trends

Telehealth Integration

The integration of telehealth and remote patient monitoring is becoming increasingly prevalent. This trend is set to impact the liquid oxygen devices market as healthcare providers use telehealth platforms to monitor and adjust oxygen therapy remotely, enhancing patient convenience and adherence to treatment.

Miniaturization and Portability

Advances in miniaturization and portable technology are making liquid oxygen devices smaller, lighter, and more convenient for patients. These developments allow patients greater mobility and the ability to lead active lives while receiving oxygen therapy.

Energy Efficiency and Sustainability

The market is witnessing a growing emphasis on sustainability and energy efficiency. Manufacturers are exploring ways to reduce energy consumption in the production and operation of liquid oxygen devices, making them more environmentally friendly.

Segmental Insights

End Use Insights

Based on end use, the homecare segment emerged as the dominant revenue contributor. This can be attributed to the growing inclination towards healthcare services provided in the comfort of one's residence, driven by patient preferences, cost efficiencies, and advancements in medical technology. Liquid oxygen devices have played a pivotal role in facilitating home-based oxygen therapy, reducing the necessity for frequent hospital visits. Notably, portable liquid oxygen devices offer patients greater mobility, enabling them to engage in their daily routines while receiving prescribed oxygen therapy. The significance of home-based care was underscored during the pandemic, as it minimizes the risk of exposure in healthcare settings, expediting the adoption of homecare solutions like liquid oxygen devices for patients in need of oxygen therapy.

Liquid Oxygen Devices Market

Download Free Sample Report

Regional Insights

North America commanded the largest market share and is poised to experience the swiftest CAGR throughout the projected period. This can be attributed to several key drivers, including the presence of an aging population, a rising prevalence of respiratory conditions, and advancements in medical technology. Notably, technological innovation has spurred the development of more efficient, portable, and user-friendly liquid oxygen concentrators. These breakthroughs have resulted in increased adoption rates and enhanced patient satisfaction levels.

Moreover, a significant number of North American patients prefer home-based healthcare to hospital stays, a trend that liquid oxygen devices have closely aligned with, as they enable patients to receive oxygen therapy in the comfort of their residences. This supports the overall shift towards home-based care. Furthermore, North America benefits from well-established regulatory frameworks for medical devices, which ensure safety and quality standards, thereby instilling trust among both patients and healthcare providers when it comes to adopting liquid oxygen devices.

Recent Developments

  • In October 2024, The East African Program on Oxygen Access launched with Unitaid announcing a US$22 million investment to support three Kenyan and Tanzanian oxygen manufacturers in establishing Africa’s first liquid oxygen regional manufacturing program. The initiative focuses on East and Southern Africa, with production facilities in Kenya and Tanzania aimed at increasing medical oxygen access across the region.
  • In April 2023, OxyGo HQ Florida LLC, a US-based manufacturer of portable oxygen concentrators, introduced the OxyHome 5L Stationary Concentrator. 
  • In June 2022, CAIRE introduced "LifeStyle," a portable oxygen concentrator designed to markedly enhance the quality of life for oxygen users throughout the United States.

Key Market Players

  • CAIRE Inc.
  • Cryofab Inc
  • Koninklijke Philips N.V.
  • Air Liquide SA
  • Inogen Inc
  • ErgoMed Inc.
  • Taylor-Wharton International LLC
  • Inova Labs
  • DeVilbiss Healthcare
  • NTK Oxygen Electronics Co. Ltd.

 By Distribution Channel

By End Use

By Region

  • Direct Sales
  • Indirect Sales
  • Hospitals
  • Outpatient Facilities
  • Homecare
  • Others
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Report Scope:

In this report, the Global Liquid Oxygen Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Liquid Oxygen Devices Market, By Distribution Channel:

o   Direct Sales

o   Indirect Sales

  • Liquid Oxygen Devices Market, By End Use:

o   Hospitals

o   Outpatient Facilities

o   Homecare

o   Others

  • Liquid Oxygen Devices Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  Germany

§  United Kingdom

§  France

§  Italy

§  Spain

o   Asia-Pacific

§  China

§  Japan

§  India

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

§  Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Liquid Oxygen Devices Market.

Available Customizations:

Global Liquid Oxygen Devices market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Liquid Oxygen Devices Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

Table of content

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.           Markets Covered

1.2.2.           Years Considered for Study

1.2.3.           Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Liquid Oxygen Devices Market Outlook

5.1.  Market Size & Forecast

5.1.1.           By Value

5.2.  Market Share & Forecast

5.2.1.           By Distribution Channel (Direct Sales, Indirect Sales)

5.2.2.           By End Use (Hospitals, Outpatient Facilities, Homecare, Others)

5.2.3.           By Region

5.2.4.           By Company (2024)

5.3.  Product Market Map

5.3.1.           By Distribution Channel

5.3.2.           By End Use

5.3.3.           By Region

6.    North America Liquid Oxygen Devices Market Outlook

6.1.  Market Size & Forecast    

6.1.1.           By Value

6.2.  Market Share & Forecast

6.2.1.           By Distribution Channel (Direct Sales, Indirect Sales)

6.2.2.           By End Use (Hospitals, Outpatient Facilities, Homecare, Others)

6.2.3.           By Country

6.3.  North America: Country Analysis

6.3.1.           United States Liquid Oxygen Devices Market Outlook

6.3.1.1.        Market Size & Forecast

6.3.1.1.1.            By Value

6.3.1.2.        Market Share & Forecast

6.3.1.2.1.            By Distribution Channel

6.3.1.2.2.            By End Use

6.3.2.           Canada Liquid Oxygen Devices Market Outlook

6.3.2.1.        Market Size & Forecast

6.3.2.1.1.            By Value

6.3.2.2.        Market Share & Forecast

6.3.2.2.1.            By Distribution Channel

6.3.2.2.2.            By End Use

6.3.3.           Mexico Liquid Oxygen Devices Market Outlook

6.3.3.1.        Market Size & Forecast

6.3.3.1.1.            By Value

6.3.3.2.        Market Share & Forecast

6.3.3.2.1.            By Distribution Channel

6.3.3.2.2.            By End Use

7.    Europe Liquid Oxygen Devices Market Outlook

7.1.  Market Size & Forecast    

7.1.1.           By Value

7.2.  Market Share & Forecast

7.2.1.           By Distribution Channel (Direct Sales, Indirect Sales)

7.2.2.           By End Use (Hospitals, Outpatient Facilities, Homecare, Others)

7.2.3.           By Country

7.3.  Europe: Country Analysis

7.3.1.           Germany Liquid Oxygen Devices Market Outlook

7.3.1.1.        Market Size & Forecast

7.3.1.1.1.            By Value

7.3.1.2.        Market Share & Forecast

7.3.1.2.1.            By Distribution Channel

7.3.1.2.2.            By End Use

7.3.2.           United Kingdom Liquid Oxygen Devices Market Outlook

7.3.2.1.        Market Size & Forecast

7.3.2.1.1.            By Value

7.3.2.2.        Market Share & Forecast

7.3.2.2.1.            By Distribution Channel

7.3.2.2.2.            By End Use

7.3.3.           France Liquid Oxygen Devices Market Outlook

7.3.3.1.        Market Size & Forecast

7.3.3.1.1.            By Value

7.3.3.2.        Market Share & Forecast

7.3.3.2.1.            By Distribution Channel

7.3.3.2.2.            By End Use

7.3.4.           Italy Liquid Oxygen Devices Market Outlook

7.3.4.1.        Market Size & Forecast

7.3.4.1.1.            By Value

7.3.4.2.        Market Share & Forecast

7.3.4.2.1.            By Distribution Channel

7.3.4.2.2.            By End Use

7.3.5.           Spain Liquid Oxygen Devices Market Outlook

7.3.5.1.        Market Size & Forecast

7.3.5.1.1.            By Value

7.3.5.2.        Market Share & Forecast

7.3.5.2.1.            By Distribution Channel

7.3.5.2.2.            By End Use

8.    Asia-Pacific Liquid Oxygen Devices Market Outlook

8.1.  Market Size & Forecast    

8.1.1.           By Value

8.2.  Market Share & Forecast

8.2.1.           By Distribution Channel (Direct Sales, Indirect Sales)

8.2.2.           By End Use (Hospitals, Outpatient Facilities, Homecare, Others)

8.2.3.           By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.           China Liquid Oxygen Devices Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.            By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.            By Distribution Channel

8.3.1.2.2.            By End Use

8.3.2.           Japan Liquid Oxygen Devices Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.            By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.            By Distribution Channel

8.3.2.2.2.            By End Use

8.3.3.           India Liquid Oxygen Devices Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.            By Value

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.            By Distribution Channel

8.3.3.2.2.            By End Use

8.3.4.           Australia Liquid Oxygen Devices Market Outlook

8.3.4.1.        Market Size & Forecast

8.3.4.1.1.            By Value

8.3.4.2.        Market Share & Forecast

8.3.4.2.1.            By Distribution Channel

8.3.4.2.2.            By End Use

8.3.5.           South Korea Liquid Oxygen Devices Market Outlook

8.3.5.1.        Market Size & Forecast

8.3.5.1.1.            By Value

8.3.5.2.        Market Share & Forecast

8.3.5.2.1.            By Distribution Channel

8.3.5.2.2.            By End Use

9.    South America Liquid Oxygen Devices Market Outlook

9.1.  Market Size & Forecast    

9.1.1.           By Value

9.2.  Market Share & Forecast

9.2.1.           By Distribution Channel (Direct Sales, Indirect Sales)

9.2.2.           By End Use (Hospitals, Outpatient Facilities, Homecare, Others)

9.2.3.           By Country

9.3.  South America: Country Analysis

9.3.1.           Brazil Liquid Oxygen Devices Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.            By Value

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.            By Distribution Channel

9.3.1.2.2.            By End Use

9.3.2.           Argentina Liquid Oxygen Devices Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.            By Value

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.            By Distribution Channel

9.3.2.2.2.            By End Use

9.3.3.           Colombia Liquid Oxygen Devices Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.            By Value

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.            By Distribution Channel

9.3.3.2.2.            By End Use

10.  Middle East and Africa Liquid Oxygen Devices Market Outlook

10.1.         Market Size & Forecast         

10.1.1.        By Value

10.2.         Market Share & Forecast

10.2.1.        By Distribution Channel (Direct Sales, Indirect Sales)

10.2.2.        By End Use (Hospitals, Outpatient Facilities, Homecare, Others)

10.2.3.        By Country

10.3.         MEA: Country Analysis

10.3.1.        South Africa Liquid Oxygen Devices Market Outlook

10.3.1.1.     Market Size & Forecast

10.3.1.1.1.         By Value

10.3.1.2.     Market Share & Forecast

10.3.1.2.1.         By Distribution Channel

10.3.1.2.2.         By End Use

10.3.2.        Saudi Arabia Liquid Oxygen Devices Market Outlook

10.3.2.1.     Market Size & Forecast

10.3.2.1.1.         By Value

10.3.2.2.     Market Share & Forecast

10.3.2.2.1.         By Distribution Channel

10.3.2.2.2.         By End Use

10.3.3.        UAE Liquid Oxygen Devices Market Outlook

10.3.3.1.     Market Size & Forecast

10.3.3.1.1.         By Value

10.3.3.2.     Market Share & Forecast

10.3.3.2.1.         By Distribution Channel

10.3.3.2.2.         By End Use

10.3.4.        Kuwait Liquid Oxygen Devices Market Outlook

10.3.4.1.     Market Size & Forecast

10.3.4.1.1.         By Value

10.3.4.2.     Market Share & Forecast

10.3.4.2.1.         By Distribution Channel

10.3.4.2.2.         By End Use

11.  Market Dynamics

11.1.         Drivers

11.2.         Challenges

12.  Market Trends & Developments

12.1.         Recent Development

12.2.         Mergers & Acquisitions

12.3.         Product Launches

13.  Porter’s Five Forces Analysis

13.1.         Competition in the Industry

13.2.         Potential of New Entrants

13.3.         Power of Suppliers

13.4.         Power of Customers

13.5.         Threat of Substitute Products

14.  Competitive Landscape

14.1.         CAIRE Inc

14.1.1.        Business Overview

14.1.2.    Company Snapshot

14.1.3.        Product Offerings

14.1.4.        Recent Developments

14.1.5.        Financials (As Reported)

14.1.6.        Key Personnel

14.1.7.        SWOT Analysis

14.2.         Cryofab Inc

14.3.         Koninklijke Philips NV

14.4.         Air Liquide SA

14.5.         Inogen Inc

14.6.     ErgoMed Inc.

14.7.     Taylor-Wharton International LLC

14.8      Inova Labs

14.9.     DeVilbiss Healthcare

14.10.   NTK Oxygen Electronics Co. Ltd.

15.  Strategic Recommendations

16.  About Us & Disclaimer

Figures and Tables

Frequently asked questions

Frequently asked questions

The market size of the Global Liquid Oxygen Devices Market was estimated to be USD 6.23 billion in 2024.

CAIRE Inc., Cryofab Inc, Koninklijke Philips NV, Air Liquide SA, Inogen Inc were some of the key players operating in the Global Liquid Oxygen Devices Market.

Regulatory compliance and quality assurance, cost and accessibility, insurance and reimbursement policies, are some of the major challenges faced by the Global Liquid Oxygen Devices Market in the upcoming years.

Increasing prevalence of respiratory diseases and aging population are the major drivers for the Global Liquid Oxygen Devices Market.

Related Reports

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.